SARS-CoV2
Showing 5026 - 5050 of 5,886
COVID-19 Mortality Prediction Model
Completed
- COVID-19
- +2 more
- COViage
-
Oakland, CaliforniaDascena
Apr 21, 2020
Long COVID Trial in Saint-Denis, Saint-Pierre (Cardiac coherence)
Not yet recruiting
- Long COVID
- Cardiac coherence
-
Saint-Denis, France
- +1 more
May 9, 2023
Sitagliptin Treatment in Diabetic COVID-19 Positive Patients
Completed
- Covid19
- Retrospective case-control analysis
-
Milan, MI, Italy
- +5 more
Jul 8, 2020
Evaluation of Immune Response in COVID-19 Patients
Unknown status
- Allergy and Immunology
- Infection Viral
- COVID-19 treatment
-
Verona, ItalyAzienda Ospedaliera Universitaria Integrata Verona
Jun 18, 2020
PIMS-TS in Intensive Care: Retrospective Cohort Trial
Recruiting
- Pims-Ts
- PIMS-TS diagnostic a treatment
-
Brno, South Moravian Region, CzechiaBrno University Hospital
Sep 7, 2022
Severe Respiratory Illness to Access the Presence of COVID-19
Unknown status
- Coronavirus Disease (COVID-19)
- COVID-19
-
Cairo, Non-US, Egypt
- +1 more
Apr 17, 2020
Ankylosing Spondylitis Trial in United States (150 mg open-label secukinumab, 150 mg double-blinded secukinumab, 300 mg
Completed
- Ankylosing Spondylitis
- 150 mg open-label secukinumab
- +2 more
-
Jonesboro, Arkansas
- +64 more
Apr 27, 2022
Mental Health in Healthcare Workers Exposed to COVID-19 Patients
Unknown status
- COVID-19
- Survey
-
Doha, QatarHamad Medical Corporation
Jul 15, 2020
Thymic Function in Patients With COVID-19
Completed
- Covid19
- Single-Nucleotide Polymorphisms (SNP) within the TCRA/D region
- +3 more
-
Neuilly-sur-Seine, FranceCMC Ambroise Paré
Apr 5, 2022
Covid19, Hypercoagulable States Nec Trial in Chandigarh (Sonoclot)
Recruiting
- Covid19
- Hypercoagulable States Nec
- Sonoclot
-
Chandigarh, IndiaPGIMER
Dec 14, 2020
Coronavirus Disease 2019 (COVID-19) Trial in Guangzhou (BM-MSCs, Placebo)
Unknown status
- Coronavirus Disease 2019 (COVID-19)
- BM-MSCs
- Placebo
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory Health, The First Affiliated
Apr 13, 2020
Influenza Infection, SAD-RV Infection and COVID-19 Trial in Shanghai (DAS181, Placebo)
Unknown status
- Influenza Infection
- SAD-RV Infection and COVID-19
- DAS181
- Placebo
-
Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiao Tong University Scho
Jul 8, 2020
Covid19, Cognitive Impairment Trial in Nashville (AKL-T01, Control Group)
Recruiting
- Covid19
- Cognitive Impairment
- AKL-T01
- Control Group
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 4, 2022
Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic
Not yet recruiting
- Tuberculosis
- 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
- +5 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Oct 11, 2021
Long COVID-19 Syndrome, Chronic Fatigue Syndrome Trial in Brazil (Fluvoxamine Maleate 100 MG, Placebo, Metformin Extended
Recruiting
- Long COVID-19 Syndrome
- Chronic Fatigue Syndrome
- Fluvoxamine Maleate 100 MG
- +2 more
-
Belo Horizonte, Minas Gerais, Brazil
- +5 more
Nov 10, 2023
COVID19, Diabetes, Hypertension Trial in Toluca de Lerdo (Nutritional support system (NSS), Conventional nutritional support
Completed
- COVID19
- +7 more
- Nutritional support system (NSS)
- Conventional nutritional support designed by hospital nutritionists
-
Toluca de Lerdo, Mexico State, MexicoISSEMYM "Arturo Montiel Rojas" Medical Center
Oct 13, 2021
Respiratory Distress Syndrome, Adult Trial in Japan (HLCM051)
Active, not recruiting
- Respiratory Distress Syndrome, Adult
- HLCM051
-
Nagoya, Aichi, Japan
- +28 more
Apr 5, 2021
COVID19, Tailored Recommendations, Citizen Self-reported Symptoms Trial in Quebec (Tailored recommendations, General
Recruiting
- COVID19
- +2 more
- Tailored recommendations
- General recommendation
-
Quebec, CanadaLaval University
Jan 6, 2021
COVID-19, Severe Pneumonia, Chinese Medicine Trial in Wuhan (Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard
Suspended
- COVID-19
- +2 more
- Yinhu Qingwen Granula
- +2 more
-
Wuhan, Hubei, China
- +3 more
Jul 4, 2021
Coronavirus Infections Trial in Sari (Convalescent Plasma)
Unknown status
- Coronavirus Infections
- Convalescent Plasma
-
Sari, Mazandaran, Iran, Islamic Republic ofImam Khomeini Hospital, Mazandaran University of Medical Science
Mar 30, 2020
CoVID-19, Chinese Medicine Trial in Jingzhou, Wuhan, Xiangyang (YinHu QingWen Decoction, YinHu QingWen Decoction(low dose),
Suspended
- CoVID-19
- Chinese Medicine
- YinHu QingWen Decoction
- +3 more
-
Jingzhou, Hubei, China
- +2 more
Jul 4, 2021
Mental Health Issue Trial in Beijing (VR collaborative visualization system)
Recruiting
- Mental Health Issue
- VR collaborative visualization system
-
Beijing, Beijing, ChinaPUMC
Mar 6, 2023
Oral Chlorine Dioxide in the Treatment of COVID 19
Unknown status
- COVID-19
- chlorine dioxide 3000 ppm
-
Bogota, Cundinamarca, Colombia
- +1 more
May 22, 2020
COVID 19 Associated Coagulopathy Trial in Iowa City, La Crosse (Intermediate dose thromboprophylaxis, Standard of Care
Recruiting
- COVID 19 Associated Coagulopathy
- Intermediate dose thromboprophylaxis
- Standard of Care thromboprophylaxis
-
Iowa City, Iowa
- +1 more
Jun 18, 2020
Treatment Efficacy Trial in Ratchathewi, Bangkok, Chiangmai (FluvoxaMINE Maleate 50 MG, Fluvoxamine, Bromhexine, Fluvoxamine,
Completed
- Treatment Efficacy
- FluvoxaMINE Maleate 50 MG
- +4 more
-
Ratchathewi, Bangkok, Thailand
- +2 more
Jun 21, 2022